白介素-1受体拮抗剂、镇痛方式与产程启动后剖宫产风险:孟德尔随机化分析
基于UK Biobank的孟德尔随机化分析纳入7731名至少16岁、前两次分娩均有完整遗传评分与分娩数据的经产妇,评估IL-1ra遗传评分与产程启动后剖宫产的关系。结果显示,在非椎管内镇痛者中,零等位基因评分者剖宫产率17.4%,高于评分≥1者的13.0%(OR 1.41;1.12-1.77)。椎管内镇痛者中各评分组剖宫产率无差异。
要点
- 非椎管内镇痛时,IL-1ra最低遗传评分者剖宫产风险更高(OR 1.41)。
- 椎管内镇痛者各遗传评分组剖宫产率无差异(18.1%-20.8%)。
- 评分≥1者接受椎管内镇痛的剖宫产风险高于非椎管内镇痛(OR 1.55)。
核心结论
- 孟德尔随机化分析提示较高的IL-1ra水平与较低的剖宫产率相关。
- 椎管内镇痛似乎会干扰这一关联。
研究设计与样本
- 在UK Biobank经产妇中开展孟德尔随机化分析,对象为≥16岁、前两次分娩分别接受非椎管内或椎管内镇痛且有完整遗传评分与分娩数据者。
- 遗传评分按rs6743376与rs1542176等位基因有无计算为0-4分,两者完全缺失时IL-1ra水平最低。
- 共7731名女性纳入分析,首次生育平均(标准差)年龄25(5)岁。
主要发现
- 非椎管内镇痛者剖宫产率随等位基因评分不同而异(χ2=12.4;P=0.015)。
- 零等位基因评分者104/596(17.4%)发生剖宫产,评分≥1者654/5015(13.0%)发生剖宫产(OR 1.41;1.12-1.77)。
- 椎管内镇痛者剖宫产率在各评分组间无差异,为18.1%-20.8%(χ2=0.29;P=0.99)。
- 零等位基因评分者818/7731(10.6%)的剖宫产与镇痛方式无关(OR 0.93;0.63-1.39)。
- 评分≥1者接受椎管内镇痛的剖宫产率更高(OR 1.55;1.35-1.79;P<0.001)。
临床怎么用
- 对拟行分娩镇痛的经产妇,可关注IL-1ra相关遗传背景与镇痛方式对剖宫产风险的潜在交互。
- 椎管内镇痛与剖宫产风险的关联在遗传评分≥1者中更明显,咨询时应结合镇痛方式个体化评估。
局限性
- 研究为UK Biobank中的孟德尔随机化分析,结论需在其他人群中验证。
- 遗传评分仅基于rs6743376与rs1542176两个位点,不能完全代表IL-1ra水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower circulating levels of the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1ra) are associated with intrapartum inflammation and epidural analgesia-related maternal fever, both of which increase the rate of obstetric interventions. We hypothesised that genetic variants determining IL-1ra levels would be associated with Caesarean delivery rates after the onset of labour. METHODS: We performed Mendelian randomisation analyses in parous women ≥16 yr old who received either non-neuraxial or neuraxial analgesia for their first two labours (UK Biobank). We used an established genetic score (calculated as 0-4, determined by the presence/absence of rs6743376 and rs1542176 alleles), in which the complete absence of both alleles causes the lowest IL-1ra levels. The primary outcome was Caesarean delivery after the onset of labour (odds ratio [OR]: 95% confidence intervals). RESULTS: There were 7731 women (mean [standard deviation] age at first birth: 25 [5] yr) who had complete genetic scores and delivery data. For women who received non-neuraxial analgesia, Caesarean delivery rates were different across allele scores (χ2=12.4; P=0.015): 104/596 (17.4%) women with zero allele score underwent Caesarean delivery, compared with 654/5015 (13.0%) with allele score ≥1 (OR 1.41; 1.12-1.77). For women who had neuraxial analgesia, Caesarean delivery was not different across allele scores, ranging from 18.1% to 20.8% (χ2=0.29; P=0.99). Caesarean delivery was independent of type of analgesia for 818/7731 (10.6%) women with zero allele scores (OR 0.93; 0.63-1.39), but was higher in women receiving neuraxial analgesia with allele scores ≥1 (OR 1.55; 1.35-1.79; P<0.001). CONCLUSIONS: Mendelian randomisation analysis suggests that higher IL-1ra levels are associated with reduced Caesarean delivery rate. Neuraxial analgesia appears to disrupt this link. CLINICAL TRIAL REGISTRATION: UK Biobank study 62745.
引用
- Ackland GL, Van Duijvenboden S, Abbott TEF, et al. Interleukin-1 receptor antagonist, mode of analgesia and risk of Caesarean delivery after onset of labour: a Mendelian randomisation analysis. Br J Anaesth. 2021. PMID: 34802694. doi:10.1016/j.bja.2021.09.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。